These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7695282

  • 1. In vitro activities of 2,2'-bipyridyl analogs against Mycobacterium leprae.
    Dhople AM, Ibanez MA, Dhople AA.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2908-9. PubMed ID: 7695282
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of 2,2'-bipyridyl analogues against Mycobacterium avium and M. tuberculosis.
    Dhople AM, Dhople AA, Ibanez MA.
    Tuber Lung Dis; 1995 Apr; 76(2):136-40. PubMed ID: 7780096
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.
    Dhople AM, Ibanez MA.
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2116-9. PubMed ID: 8540726
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine.
    Newman SL, Gootee L, Stroobant V, van der Goot H, Boelaert JR.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1824-9. PubMed ID: 7486926
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of sitafloxacin (DU-6859a), either singly or in combination with rifampin analogs, against Mycobacterium leprae.
    Dhople AM, Namba K.
    J Infect Chemother; 2003 Mar; 9(1):12-5. PubMed ID: 12673400
    [Abstract] [Full Text] [Related]

  • 6. In-vitro activity of three new fluoroquinolones and synergy with ansamycins against Mycobacterium leprae.
    Dhople AM, Ibanez MA.
    J Antimicrob Chemother; 1993 Sep; 32(3):445-51. PubMed ID: 8262866
    [Abstract] [Full Text] [Related]

  • 7. Influence of membrane composition of various parasites on the inhibitory activity of a series of bipyridyl analogues.
    Seydel JK, van der Goot H, Timmerman H.
    Chemotherapy; 1994 Sep; 40(2):124-35. PubMed ID: 8131634
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.
    Dhople AM.
    Int J Antimicrob Agents; 1999 Aug; 12(4):319-23. PubMed ID: 10493608
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of phenothiazine-type calmodulin antagonists against Mycobacterium leprae.
    Dhople AM.
    Microbios; 1999 Aug; 98(390):113-21. PubMed ID: 10624009
    [Abstract] [Full Text] [Related]

  • 10. 2,2'-Bipyridyl-6-carboxamidoximes with potential antitumor and antimicrobial properties.
    Cristalli G, Franchetti P, Grifantini M, Ripa S.
    Farmaco Sci; 1986 Jul; 41(7):499-507. PubMed ID: 3743743
    [Abstract] [Full Text] [Related]

  • 11. The activity of rifabutin against Mycobacterium leprae in armadillos.
    Dhople AM, Williams SL.
    Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
    [Abstract] [Full Text] [Related]

  • 12. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR, Hébrant F.
    Arzneimittelforschung; 1980 Jan; 30(12):2099-103. PubMed ID: 7011330
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM.
    Indian J Lepr; 1997 Jan; 69(4):377-84. PubMed ID: 9474513
    [Abstract] [Full Text] [Related]

  • 14. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM, Ibanez MA, Gardner GD.
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [Abstract] [Full Text] [Related]

  • 15. 2,2'-Bipyridyl-6-carbothioamide derivatives as potential antitumor agents.
    Antonini I, Cristalli G, Franchetti P, Grifantini M, Martelli S, Filippeschi S.
    Farmaco Sci; 1986 May; 41(5):346-54. PubMed ID: 3720944
    [Abstract] [Full Text] [Related]

  • 16. An in vitro culture method for screening new drugs against Mycobacterium leprae.
    Dhople AM, Ortega I.
    Indian J Lepr; 1990 May; 62(1):66-75. PubMed ID: 2193063
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM, Dimova V.
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM, Strong LC, Meindl W, Schoenenberger H, Gardner GD.
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [Abstract] [Full Text] [Related]

  • 19. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB, Hilson GR.
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract] [Full Text] [Related]

  • 20. Susceptibility of Mycobacterium leprae to the bactericidal activity of mouse peritoneal macrophages and to hydrogen peroxide.
    Sharp AK, Colston MJ, Banerjee DK.
    J Med Microbiol; 1985 Feb; 19(1):77-84. PubMed ID: 3881593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.